Shatila, Hibeh
Ghazal, Nour
Bukshaisha, Ghalya
Al-Zeyara, Shaikha
Khoury, Cosette Fakih El
Bassil, Maya
Article History
Received: 30 March 2024
Accepted: 5 September 2024
First Online: 30 September 2024
Declarations
:
: The ethical approval for the overarching study protocol for the larger Qatar Biobank (QBB) cohort was obtained from the Hamad Medical Corporation Ethics Committee in 2011 and continued with the QBB Institutional Review Board (IRB) from 2017 onward. It is renewed on an annual basis. QBB data collection is in compliance with the Helsinki Declaration and utilized deidentified information from adults visiting the Qatar Biobank clinics. Informed consent was obtained from all subjects involved in the study. Study protocol for the access to QBB data for the current study was submitted to, and reviewed by, the Qatar Biobank Institutional Review Board (QBB IRB) in Qatar, which granted an exemption review under approval number Ex-2022-QF-QBB-RES-ACC-0101–209.
: Not Applicable.
: The authors declare no competing interests.